Bioprosthetic valve monitoring in patients with carcinoid heart disease

Bioprosthetic valve monitoring in patients with carcinoid heart disease

BackgroundCarcinoid heart disease (CnHD) is a frequent cause of morbidity and mortality in patients with neuroendocrine tumors and carcinoid syndrome. Although valve replacement surgery appears to decrease all-cause mortality in patients with advanced CnHD, few studies have investigated the outcomes...

Full description

Bibliographic Details
Main Authors: Kevin A. Honan, Saamir Hassan, Anita Deswal, Joerg Herrmann, Juhee Song, Dominique Monlezun, Daniel Halperin, Armeen Mahvash, Arvind Dasari, Efstratios Koutroumpakis, Mehmet Akay, Dinu-Valentin Balanescu, Ismael Salas de Armas, Manish Patel, Sriram Nathan, Biswajit Kar, Konstantinos Marmagkiolis, Juan Lopez-Mattei, Jay Patel, Igor Gregoric, James Yao, Cezar A. Iliescu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardio-oncology
carcinoid heart disease
telotristat ethyl
peptide receptor radionuclide therapy (PRRT)
pulmonary valve
tricuspid valve repair
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1072890/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1072890/full

Similar Items